Compare WING & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WING | MIR |
|---|---|---|
| Founded | 1994 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Restaurants | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.5B |
| IPO Year | 2015 | N/A |
| Metric | WING | MIR |
|---|---|---|
| Price | $156.79 | $18.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 27 | 8 |
| Target Price | ★ $295.92 | $27.25 |
| AVG Volume (30 Days) | 1.4M | ★ 3.6M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 67.84 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $696,853,000.00 | N/A |
| Revenue This Year | $17.20 | $23.95 |
| Revenue Next Year | $15.86 | $7.32 |
| P/E Ratio | ★ $146.46 | $195.00 |
| Revenue Growth | ★ 11.35 | N/A |
| 52 Week Low | $116.35 | $16.43 |
| 52 Week High | $388.14 | $30.28 |
| Indicator | WING | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 47.29 |
| Support Level | $142.24 | $16.98 |
| Resistance Level | $285.21 | $20.70 |
| Average True Range (ATR) | 8.49 | 0.80 |
| MACD | 5.16 | -0.08 |
| Stochastic Oscillator | 91.69 | 62.94 |
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.